Skip to main content
森萱医药 logo

森萱医药 — Investor Relations & Filings

Ticker · 920946 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 417 across all filing types
Latest filing 2022-10-27 Interim / Quarterly Rep…
Country CN China
Listing Beijing Stock Exchange 920946

About 森萱医药

https://www.senxuan.cn/

Jiangsu Senxuan Pharmaceutical Co., Ltd. specializes in the research, development, and production of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and specialized fine chemicals. The company’s product portfolio includes key intermediates for antiviral medications, such as those used in the treatment of HIV, and anticonvulsant agents like Primidone. Additionally, it produces high-purity chemical solvents including 1,4-dioxane and 1,3-dioxolane for diverse industrial applications. Senxuan Pharmaceutical maintains a focus on advanced chemical synthesis and large-scale manufacturing capabilities, adhering to international quality standards to support the global life sciences and chemical sectors. Its operations are characterized by a commitment to technical innovation and the supply of critical chemical building blocks for complex therapeutic formulations.

Recent filings

Filing Released Lang Actions
2022年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "江苏森萱医药股份有限公司 2022 年第三季度报告" which translates to "Jiangsu Senxuan Pharmaceutical Co., Ltd. 2022 Third Quarter Report." It contains detailed financial data, including balance sheets, income statements, cash flow statements, and explanations of significant changes in financial data for the period July 1, 2022 to September 30, 2022. The document also includes management assurances about the accuracy of the report, notes that the report is unaudited, and provides detailed notes on non-recurring items and shareholder information. The length is about 15,000 characters, indicating a comprehensive report rather than a brief announcement. The content and structure clearly identify this as a quarterly financial report containing substantive financial data and analysis for a period shorter than a full fiscal year. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q3 2022
2022-10-27 Chinese
第三届监事会第十五次会议决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Jiangsu Senxuan Pharmaceutical Co., Ltd. It details the meeting date, attendance, and the approval of the company's 2022 third quarter report. The document does not contain the actual financial report but references the report disclosed on the Beijing Stock Exchange information platform. The document is short (941 characters) and serves as an announcement of the meeting resolution and voting results rather than the report itself. Therefore, it fits best under Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-10-27 Chinese
第三届董事会第十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 17th meeting of the 3rd Board of Directors of Jiangsu Senxuan Pharmaceutical Co., Ltd. It includes details about the meeting date, attendance, and the approval of the company's 2022 third quarter report. The document does not contain the actual financial report but references the report published on the Beijing Stock Exchange information disclosure platform. The document is primarily about board meeting decisions and resolutions, not the report itself. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is an announcement of meeting resolutions, not a full report or transcript.
2022-10-27 Chinese
关于完成工商变更登记并取得营业执照的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Jiangsu Senxuan Pharmaceutical Co., Ltd. regarding the completion of industrial and commercial registration changes and obtaining a new business license. It details the change in the company's business scope and the completion of related registration procedures. The document is short (1021 characters) and serves as an official notice of a corporate registration update rather than a financial report or detailed management information. It does not contain financial data, audit information, or meeting materials. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-09-22 Chinese
2022年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 2022 second extraordinary general meeting of shareholders of Jiangsu Senxuan Pharmaceutical Co., Ltd. It includes details about the meeting date, location, attendance, agenda items, voting results, and legal opinions confirming the validity of the meeting and resolutions. The document does not contain financial statements or detailed financial analysis but focuses on the voting results and meeting procedures. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (1631 characters), and it is not merely announcing the publication of a report but is itself the voting results announcement. Therefore, the correct classification is DVA with high confidence.
2022-09-15 Chinese
公司章程
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of Jiangsu Senxuan Pharmaceutical Co., Ltd., effective from the 2022 second extraordinary shareholders meeting. It contains detailed provisions on company organization, shareholder rights, board and management structure, share issuance and transfer, shareholder meetings, and other governance matters. It is a comprehensive governance document outlining the internal rules and regulations of the company. There is no indication that this is a report of financial results, audit, or a meeting presentation. It is not an announcement or a brief notice but a full text of the company's articles of association. Therefore, the document fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2022-09-15 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.